Kleanthis Xanthopoulos
Currently the president and CEO of Regulus Therapeutics, Xanthopoulos co-founded Anadys Pharmaceuticals where he served as president and CEO from 2000 to 2006.
He remained a director until its acquisition by Roche in 2011.
Xanthopoulos said: “I am very excited to join the board of this rapidly growing specialty bio-pharmaceutical company.”